PTC Bio (PTCT) - מקדם חוב לטווח ארוך להון

This price chart on the GURU.Markets platform for PTC Therapeutics, Inc. (PTCT) captured the 0.00 metric. The business relies on developing treatments for rare genetic pathologies, which guarantees a perpetual cash flow due to lifelong therapy. The company is also developing drugs to combat rare nervous system disorders, utilizing a global supply chain and strict temperature controls to maintain drug efficacy.

This ratio determines the share of long-term liabilities within the equity structure, measuring financial stability and the company's degree of dependence on external borrowing. By analyzing the long-term debt-to-equity trend on GURU.Markets, an investor can see how the large-scale implementation of robotic systems in biopharmaceuticals at PTC Therapeutics, Inc. (PTCT) requires capital expenditures, impacting the debt load to accelerate the development of new drugs.